Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

188 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Difficulties in the therapy of primary amyloidosis].
Adam Z, Elbl L, Vorlícek J, Králová E, Novotná H, Hájek R, Hejlová N. Adam Z, et al. Among authors: vorlicek j. Vnitr Lek. 1994 Sep;40(9):595-9. Vnitr Lek. 1994. PMID: 7975364 Czech.
[Therapeutic use of interferon beta].
Adam Z, Vorlícek J. Adam Z, et al. Among authors: vorlicek j. Vnitr Lek. 1994 May;40(5):329-33. Vnitr Lek. 1994. PMID: 8023478 Review. Czech.
Therapy of anemia in patients with multiple myeloma.
Adam Z, Krahulová M, Spelda S, Vorlícek J, Hejlová N, Hájek R, Tomíska M. Adam Z, et al. Among authors: vorlicek j. Acta Med Austriaca. 1995;22(4):59-64. Acta Med Austriaca. 1995. PMID: 8835422
Current role of immunotherapy in multiple myeloma.
Hájek R, Adam Z, Krivanová A, Doubek M, Korístek Z, Vorlícek J. Hájek R, et al. Among authors: vorlicek j. Acta Med Austriaca. 1998;25(3):79-85. Acta Med Austriaca. 1998. PMID: 9816399 Review.
[Autologous transplantation of peripheral hematopoietic cells and subsequent maintenance therapy with interferon alpha or interferon alpha and dexamethasone in patients with multiple myeloma--results from the 4W randomized clinical trial of the Czech Myeloma Group].
Krejcí M, Hájek R, Scudla V, Bacovský J, Indrák K, Faber E, Koza V, Schützová M, Kuca B, Sumná E, Franková H, Lehanka F, Gumulec J, Stavarová Y, Rezek Z, Praskac P, Cahová S, Vránová M, Veprek K, Januska J, Kessler P, Pozdĕnová V, Walterová L, Stefánek I, Hausdorf P, Meluzínová I, Novosadová L, Lenícková S, Dusek L, Syobodník A, Králová E, Adam Z, Mayer J, Vorlícek J. Krejcí M, et al. Among authors: vorlicek j. Vnitr Lek. 2001 Sep;47 Suppl 1:40-7. Vnitr Lek. 2001. PMID: 11693062 Clinical Trial. Czech.
188 results